Elements of diabetic nephropathy in a patient with GLUT 2 deficiency (Q46804403)

25 December 2017

title

Elements of diabetic nephropathy in a patient with GLUT 2 deficiency (English)

1 reference

25 December 2017

main subject

3-deoxy-keto-D-fructose

1 reference

ChEBI release 2020-05-28

1 reference

1

1 reference

25 December 2017

author name string

John W Baynes

2

1 reference

25 December 2017

Kevin J Wells-Knecht

3

1 reference

25 December 2017

Benjamin S Szwergold

4

1 reference

25 December 2017

René Santer

5

1 reference

25 December 2017

publication date

8 November 2005

1 reference

25 December 2017

Molecular Genetics and Metabolism

published in

1 reference

25 December 2017

volume

86

1 reference

25 December 2017

issue

4

1 reference

25 December 2017

page(s)

473-477

1 reference

25 December 2017

cites work

Fanconi-Bickel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.09.010

Mutations in GLUT2, the gene for the liver-type glucose transporter, in patients with Fanconi-Bickel syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.09.010

Sequence, tissue distribution, and chromosomal localization of mRNA encoding a human glucose transporter-like protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.09.010

Detection of 3-deoxyfructose and 3-deoxyglucosone in human urine and plasma: evidence for intermediate stages of the Maillard reaction in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.09.010

Diabetes-like renal glomerular disease in Fanconi-Bickel syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.09.010

Intakes and food sources of fructose in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.09.010

The mutation spectrum of the facilitative glucose transporter gene SLC2A2 (GLUT2) in patients with Fanconi-Bickel syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.09.010

Renal disease in type I glycogen storage disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.09.010

Hyperfiltration and renal disease in glycogen storage disease, type I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.09.010

Teratogenicity of 3-deoxyglucosone and diabetic embryopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.09.010

Identification, cloning, and heterologous expression of a mammalian fructosamine-3-kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.09.010

Metabolism of fructose-3-phosphate in the diabetic rat lens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.09.010

Increased erythrocyte 3-DG and AGEs in diabetic hemodialysis patients: role of the polyol pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.09.010

IMPAIRED RENAL TUBULAR FUNCTION INDUCED BY SUGAR INFUSION IN MAN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.09.010

Molecular Analysis of the SGLT2 Gene in Patients with Renal Glucosuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.09.010

Fanconi-Bickel syndrome--the original patient and his natural history, historical steps leading to the primary defect, and a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.09.010

3-Deoxyglucosone: metabolism, analysis, biological activity, and clinical implication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.09.010

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YMGME.2005.09.010

1 reference

25 December 2017

PubMed ID

16288895

1 reference

25 December 2017